The University of Sheffield
clinical effectiveness of biophosphates.pdf (491.4 kB)

Clinical effectiveness of bisphosphonates for prevention of fragility fractures: a systematic review and network meta-analysis

Download (491.4 kB)
posted on 2020-03-09, 16:20 authored by Jean SandersonJean Sanderson, Marrissa Martyn-St James, Sarah DaviesSarah Davies, John Stevens, Edward Goka, Susie Sadler
BACKGROUND Osteoporosis is characterised by low bone mass and structural deterioration of bone tissue, with a consequent increase in susceptibility to fragility fracture. Fractures cause significant pain, disability and loss of independence and can be fatal. [1] OBJECTIVE To assess the relative efficacy of bisphosphonates (alendronate, risedronate, ibandronate and zoledronate) for the treatment of Osteoporosis using a network meta-analysis (NMA).



  • There is no personal data or any that requires ethical approval


  • The data complies with the institution and funders' policies on access and sharing

Sharing and access restrictions

  • The data can be shared openly

Data description

  • The file formats are open or commonly used

Methodology, headings and units

  • Headings and units are explained in the files